The most frequently altered genes in ER+ BC were TP53 (38%), ESR1 (31%), PIK3CA (31%), CDH1 (10%), and ERBB2 (8%) (supplementary Figure S1, available at Annals of Oncology online). This evidence concerns the gene CDH1 and breast cancer.